Ann: MSB Enters Into $75 Million Non-Dilutive Credit Facility, page-186

AGVHD sales in other markets where product has been approved are immaterial and minimal. If this is the only product they can get over the line in US markets.. then the company will fail. The real coin is in CHF and CLBP of which we need to wait for confirmation and that is why I hold. Unhappy with the loan shark deal because it is highlighting that a partner is still unwilling to take on AGVHD stand alone and cant see value at this point. Partners seem to be waiting for the far more riskier treatment read outs before committing coin. Now mesoblast have no choice but to resort to a debt deal to pay the wages. All else is fluff to the sp without a concrete partnership and I fear a gradual decline back to $1.30s is taking place before read outs on the riskier treatments.